MaxLinear (MXL) has had the highest return since January 1, 2026 and this year by a mid-cap US stock, returning 513%.
| ASSET | % RETURN |
|---|---|
MaxLinear (MXL) | 513.01% |
AXT (AXTI) | 388.72% |
Iovance Biotherapeutics (IOVA) | 366.19% |
Aehr Test Systems (AEHR) | 338.34% |
Bandwidth (BAND) | 286.93% |
Erasca (ERAS) | 285.44% |
Abcellera Biologics (ABCL) | 284.5% |
Pulse Biosciences (PLSE) | 259.73% |
Hyperliquid Strategies Inc Common Stock (PURR) | 254.11% |
CareDx (CDNA) | 238.59% |
Kodiak Sciences (KOD) | 230.85% |
Ichor (ICHR) | 225.38% |
Penguin Solutions (PENG) | 222.99% |
Veradermics (MANE) | 220.47% |
PBF Energy (PBF) | 208.86% |
Okeanis Eco Tankers (ECO) | 208.47% |
Cohu (COHU) | 205.35% |
Silicon Motion Technology (SIMO) | 203.77% |
Calumet Specialty Products Partners (CLMT) | 184.32% |
Iridium Communications (IRDM) | 183.42% |
Ultra Clean (UCTT) | 180.18% |
International Seaways (INSW) | 177% |
Enliven Therapeutics (ELVN) | 173.48% |
Ringcentral (RNG) | 167.94% |
Oruka Therapeutics (ORKA) | 164.53% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.